Published in Minerva Med on March 10, 1986
Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost (2006) 2.99
Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology (2005) 2.86
Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost (2005) 1.83
Marginal papular acrokeratodermas: a unified nosography for focal acral hyperkeratosis, acrokeratoelastoidosis and related disorders. Dermatology (1994) 1.74
Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol (1995) 1.55
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med (1997) 1.45
Proton radiography of inertial fusion implosions. Science (2008) 1.44
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Liver transplantation in severe von Willebrand disease. Lancet (1991) 1.40
Frequency of factor V Arg506 Gln in Italians. Thromb Haemost (1996) 1.39
Familial aberrant mammary tissue: a clinicoepidemiological survey of 18 cases. Dermatology (1995) 1.39
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost (2001) 1.34
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation (1994) 1.28
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Startle reflex and emotion modulation impairment after a right amygdala lesion. Brain (1996) 1.19
Charged-particle probing of x-ray-driven inertial-fusion implosions. Science (2010) 1.18
Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost (1997) 1.17
Noninflammatory focal dermal elastolysis. J Am Acad Dermatol (1992) 1.16
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer (1996) 1.11
DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood (1984) 1.10
Reply to: 'the discovery of a new class of synaptic transmitters in smooth muscle fifty years ago and amelioration of coronary artery thrombosis'. Acta Physiol (Oxf) (2013) 1.09
Multicenter study of homocysteine measurement--performance characteristics of different methods, influence of standards on interlaboratory agreement of results. Thromb Haemost (2001) 1.08
Supernumerary nipple in association with Becker nevus vs. Becker nevus syndrome: a semantic problem only. Am J Med Genet (1998) 1.08
Cirrhosis associated with multiple transfusions in thalassaemia. Arch Dis Child (1984) 1.07
Clinical features of 36 cases of amelanotic melanomas and considerations about the relationship between histologic subtypes and diagnostic delay. J Eur Acad Dermatol Venereol (2008) 1.06
Epidemiological, clinical and allergological observations on pompholyx. Contact Dermatitis (1992) 1.06
Resistive wall mode instability at intermediate plasma rotation. Phys Rev Lett (2010) 1.05
Mechanisms of platelet aggregation. Curr Opin Hematol (2001) 1.02
Increased fibrinopeptide A after prothrombin complex concentrates. Thromb Haemost (1980) 1.02
p53 accumulation in ovarian carcinomas and its prognostic implications. Hum Pathol (1993) 0.97
Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia (2006) 0.96
[Foreign body decubitus: unusual cause of acute appendicitis]. Minerva Chir (1993) 0.96
Production of a monoclonal antibody directed against the recombinant SEL1L protein. Int J Biol Markers (2002) 0.96
Further observations on the effect of hydrogen ion on the pulmonary circulation. Circulation (1967) 0.96
Measurement of form-factor-independent observables in the decay B0→K(*0)μ(+)μ(-). Phys Rev Lett (2013) 0.96
Observation of a resonance in B+ → K+ μ+ μ- decays at low recoil. Phys Rev Lett (2013) 0.95
Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet (1987) 0.95
Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol (1992) 0.95
Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas. Genomics (1997) 0.94
Group A streptococcal meningitis in the antibiotic era. Eur J Clin Microbiol Infect Dis (1999) 0.94
High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb (1994) 0.93
Extreme particle acceleration in the microquasar Cygnus X-3. Nature (2009) 0.93
A kinetic study of Saccharomyces strains: Performance at high sugar concentrations. Biotechnol Bioeng (1985) 0.92
Cadmium biosorption on Spirulina platensis biomass. Bioresour Technol (2007) 0.92
[Project, natural lighting and comfort indoor]. Ann Ig (2008) 0.92
Rare bleeding disorders. Haemophilia (2008) 0.92
The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients. Ann Oncol (1997) 0.91
Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease). Eur J Clin Invest (1984) 0.91
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur Heart J (2013) 0.91
Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism. J Thromb Haemost (2013) 0.90
Self-detected cutaneous melanomas in Italian patients. Clin Exp Dermatol (2004) 0.90
Generalized measurable ignition criterion for inertial confinement fusion. Phys Rev Lett (2010) 0.90
von Willebrand disease: laboratory aspects of diagnosis and treatment. Haemophilia (2004) 0.90
Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res (1991) 0.89
Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis. Thromb Haemost (1986) 0.89
Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost (2011) 0.89
Eruptive dermatofibromas and immunosuppression. Eur J Dermatol (1999) 0.88
Clinical features and histologic pattern analysis of pigmented basal cell carcinomas in an Italian population. J Dermatol (1998) 0.87
Effect of platelet count on platelet aggregation measured with impedance aggregometry (Multiplate™ analyzer) and with light transmission aggregometry. J Thromb Haemost (2013) 0.86
Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets. Blood (1987) 0.86
Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. J Thromb Haemost (2007) 0.86
High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding. Dig Liver Dis (2008) 0.86
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma). Eur J Cancer Clin Oncol (1989) 0.86
Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol (1995) 0.85
Effect of collisionality on kinetic stability of the resistive wall mode. Phys Rev Lett (2011) 0.85
Hepatic conversion of amino nitrogen to urea nitrogen in hypothyroid patients and upon L-thyroxine therapy. Metabolism (1993) 0.84
Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment. Thromb Haemost (1998) 0.84
[A hyperhomocysteinemia study in a population with a familial factor for acute myocardial infarct and sudden cardiac death at a young age]. Cardiologia (1999) 0.84
Risk management of HBsAg or anti-HCV positive healthcare workers in hospital. Dig Liver Dis (2001) 0.84
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential. J Thromb Haemost (2008) 0.83
Platelet survival and thrombosis. Arteriosclerosis (1983) 0.83
First evidence for the decay B(s)(0)→μ+ μ-. Phys Rev Lett (2013) 0.83
Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival. Thromb Res (1985) 0.83
[Antiblastic drugs and pregnancy. Apropos of a case treated before and during pregnancy with cyclophosphamide for malignant lymphatic neoplasms and with the birth of a living and lively full-term fetus and followed by another pregnancy with similar result]. Ann Ostet Ginecol Med Perinat (1966) 0.83
A role for dopamine in growth hormone regulation in the dog. Endocrinology (1981) 0.83
An automatic contour propagation method to follow parotid gland deformation during head-and-neck cancer tomotherapy. Phys Med Biol (2011) 0.83
Usefulness of a flow cytometric analysis of intraplatelet vasodilator-stimulated phosphoprotein phosphorylation for the detection of patients with genetic defects of the platelet P2Y(12) receptor for ADP. J Thromb Haemost (2010) 0.83
The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation. Thromb Haemost (1999) 0.83
Resistive wall mode in collisionless quasistationary plasmas. Phys Rev Lett (2004) 0.83
Polythelia within Becker's naevus. Dermatology (1998) 0.82
Fusion yield enhancement in magnetized laser-driven implosions. Phys Rev Lett (2011) 0.82
SEL1L, the human homolog of C. elegans sel-1: refined physical mapping, gene structure and identification of polymorphic markers. Hum Genet (2000) 0.82
[Formulation and stability of suspensions for preclinical study]. Boll Chim Farm (1997) 0.82
Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients. Blood (1987) 0.82
Cardiac relapses in myeloid leukemia: case report and review of the literature. Pediatr Hematol Oncol (1987) 0.82
Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension. Thromb Res (1997) 0.82
Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation. J Thromb Haemost (2014) 0.81
Measurement of the CP asymmetry in B(+)→K(+)μ(+)μ(-) decays. Phys Rev Lett (2013) 0.81
Desmopressin and blood loss after cardiac surgery. Lancet (1993) 0.81
Both unilateral naevus achromicus and congenital agminated Spitz naevi in a checkerboard mosaic pattern. Br J Dermatol (2001) 0.81
Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions? Minerva Anestesiol (2010) 0.81
Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. Thromb Haemost (1985) 0.81
APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease. Neurology (1999) 0.81
Peripheral blood lymphocyte subpopulations in patients with viral warts. Acta Derm Venereol (1986) 0.81
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost (2014) 0.81